Estibaliz Lazaro

6.9k total citations
156 papers, 2.8k citations indexed

About

Estibaliz Lazaro is a scholar working on Rheumatology, Immunology and Infectious Diseases. According to data from OpenAlex, Estibaliz Lazaro has authored 156 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Rheumatology, 46 papers in Immunology and 31 papers in Infectious Diseases. Recurrent topics in Estibaliz Lazaro's work include Systemic Lupus Erythematosus Research (41 papers), HIV Research and Treatment (22 papers) and HIV/AIDS drug development and treatment (18 papers). Estibaliz Lazaro is often cited by papers focused on Systemic Lupus Erythematosus Research (41 papers), HIV Research and Treatment (22 papers) and HIV/AIDS drug development and treatment (18 papers). Estibaliz Lazaro collaborates with scholars based in France, United States and Spain. Estibaliz Lazaro's co-authors include P. Duffau, Christophe Richez, Patrick Blanco, Marie‐Elise Truchetet, Jean‐Luc Pellegrin, Cécile Contin‐Bordes, Julien Sénéschal, Noémie Gensous, Jean‐François Viallard and D. Neau and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Estibaliz Lazaro

142 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Estibaliz Lazaro France	30	1.1k	895	536	461	412	156	2.8k
Jean‐Luc Pellegrin France	34	1.1k 1.1×	733 0.8×	1.1k 2.1×	407 0.9×	875 2.1×	124	4.0k
Eduardo Fernández‐Cruz Spain	30	1.3k 1.2×	282 0.3×	417 0.8×	191 0.4×	482 1.2×	121	2.5k
Adrian Ciurea Switzerland	30	1.3k 1.3×	1.7k 1.9×	242 0.5×	229 0.5×	146 0.4×	104	2.9k
Tim Niehues Germany	31	1.5k 1.4×	292 0.3×	525 1.0×	732 1.6×	117 0.3×	153	3.3k
Anthony S. Fauci United States	14	925 0.9×	819 0.9×	556 1.0×	298 0.6×	975 2.4×	15	3.5k
L W Poulter United Kingdom	32	1.4k 1.3×	539 0.6×	199 0.4×	259 0.6×	185 0.4×	75	3.3k
Michel Delahousse France	30	1.1k 1.1×	584 0.7×	262 0.5×	340 0.7×	38 0.1×	65	3.3k
Pierre Merville France	42	2.5k 2.3×	235 0.3×	315 0.6×	417 0.9×	116 0.3×	167	5.5k
Jean‐François Viallard France	31	1.8k 1.7×	451 0.5×	283 0.5×	218 0.5×	51 0.1×	171	3.8k
Lionel Couzi France	35	1.8k 1.7×	266 0.3×	261 0.5×	309 0.7×	64 0.2×	142	4.2k

Countries citing papers authored by Estibaliz Lazaro

Since Specialization

Citations

This map shows the geographic impact of Estibaliz Lazaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Estibaliz Lazaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Estibaliz Lazaro more than expected).

Fields of papers citing papers by Estibaliz Lazaro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Estibaliz Lazaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Estibaliz Lazaro. The network helps show where Estibaliz Lazaro may publish in the future.

Co-authorship network of co-authors of Estibaliz Lazaro

This figure shows the co-authorship network connecting the top 25 collaborators of Estibaliz Lazaro. A scholar is included among the top collaborators of Estibaliz Lazaro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Estibaliz Lazaro. Estibaliz Lazaro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rivière, Étienne, Olivier Mansier, Alexandre Guy, et al.. (2025). TRAKJAK: a complete blood count-based prediction of polycythemia vera at initial erythrocytosis workup to reduce financial and ecological costs. The American Journal of Medicine. 139(3). 350–360.

Mercié, P., Étienne Rivière, Noémie Gensous, et al.. (2025). Place de la chitotriosidase au sein des biomarqueurs sériques de la sarcoïdose : une revue narrative de la littérature. La Revue de Médecine Interne. 46(9). 517–528.

Boucly, Athénaïs, Stéphane Mitrovic, Maryvonnick Carmagnat, et al.. (2025). Pulmonary arterial hypertension in adults with Still’s disease: another pulmonary manifestation associated with HLA-DRB1*15. Annals of the Rheumatic Diseases. 84(9). 1538–1548.

Richez, Christophe, Estibaliz Lazaro, Julien Sénéschal, & Lionel Couzi. (2024). Lupus eritematoso sistémico. 57(2). 1–20.

Rivière, Étienne, Rodolphe Thiébaut, Estibaliz Lazaro, et al.. (2023). Assessment of circulating blood lymphocytes in adult patients on rituximab to treat immune thrombocytopenia: Circulating number of NK cells is associated with the response at 6 months. British Journal of Haematology. 202(1). 159–167. 4 indexed citations

Guimard, Thomas, Estibaliz Lazaro, Olivia Peuchant, et al.. (2023). Case Studies and Literature Review of Francisella tularensis–Related Prosthetic Joint Infection. Emerging infectious diseases. 29(6). 1118–1126. 5 indexed citations

Gensous, Noémie, Estibaliz Lazaro, Patrick Blanco, & Christophe Richez. (2023). Anifrolumab: first biologic approved in the EU not restricted to patients with a high degree of disease activity for the treatment of moderate to severe systemic lupus erythematosus. Expert Review of Clinical Immunology. 20(1). 21–30. 10 indexed citations

Gensous, Noémie, Patrick Blanco, Estibaliz Lazaro, et al.. (2022). Pilot study on accelerated aging in lupus using epigenetic biomarkers of age. Lupus. 32(1). 129–135. 2 indexed citations

Duval, Fanny, C. Greib, Estibaliz Lazaro, et al.. (2021). Myasthenia gravis and paroxysmal nocturnal hemoglobinuria after thymectomy: A rare association. SHILAP Revista de lepidopterología. 2(4). 834–837. 1 indexed citations

10.

Morel, Jacques, Anne Tournadre, Jérémie Sellam, et al.. (2021). Practical management of patients on anti-IL6R therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI). Joint Bone Spine. 88(4). 105221–105221.

11.

Henrot, Pauline, Valérie Jolivel, Hamid Rezvani, et al.. (2020). Decreased CCN3 in Systemic Sclerosis Endothelial Cells Contributes to Impaired Angiogenesis. Journal of Investigative Dermatology. 140(7). 1427–1434.e5. 13 indexed citations

12.

Jacquemin, C., Jean‐François Augusto, Marc Scherlinger, et al.. (2018). OX40L/OX40 axis impairs follicular and natural Treg function in human SLE. JCI Insight. 3(24). 62 indexed citations

13.

Gensous, Noémie, et al.. (2017). Lupus érythémateux systémique et contraception : revue systématique de la littérature. La Revue de Médecine Interne. 38(6). 358–367. 6 indexed citations

14.

Vera, César García, et al.. (2017). Test rápido de detección de antígeno estreptocócico en faringoamigdalitis: impacto sobre el uso de antibióticos. Pediatría Atención Primaria. 19(76). 345–354. 4 indexed citations

15.

Gensous, Noémie, Thomas Barnetche, Patrick Blanco, et al.. (2017). Predictive biological markers of systemic lupus erythematosus flares: a systematic literature review. Arthritis Research & Therapy. 19(1). 238–238. 61 indexed citations

16.

Truchetet, Marie‐Elise, Valérie Jolivel, Isabelle Douchet, et al.. (2016). Platelets Induce Thymic Stromal Lymphopoietin Production by Endothelial Cells: Contribution to Fibrosis in Human Systemic Sclerosis. Arthritis & Rheumatology. 68(11). 2784–2794. 37 indexed citations

17.

Lazaro, Estibaliz, et al.. (2013). Romiplostim as early treatment for refractory primary immune thrombocytopenia. International Journal of Hematology. 98(5). 520–524. 13 indexed citations

18.

Bénard, Antoine, J.F. Tessier, Françoise Bonnet, et al.. (2006). HIV infection and tobacco smoking behaviour: prospects for prevention? ANRS CO3 Aquitaine Cohort, 2002.. PubMed. 10(4). 378–83. 35 indexed citations

19.

Fleury, Hervé, Thomas d’Aquin Toni, Phạm Văn Hưng, et al.. (2006). Susceptibility to Antiretroviral Drugs of CRF01_AE, CRF02_AG, and Subtype C Viruses from Untreated Patients of Africa and Asia: Comparative Genotypic and Phenotypic Data. AIDS Research and Human Retroviruses. 22(4). 357–366. 32 indexed citations

20.

Toni, Thomas d’Aquin, Bernard Masquelier, Estibaliz Lazaro, et al.. (2005). Characterization of Nevirapine (NVP) Resistance Mutations and HIV Type 1 Subtype in Women from Abidjan (Côte d'Ivoire) After NVP Single-Dose Prophylaxis of HIV Type 1 Mother-to-Child Transmission. AIDS Research and Human Retroviruses. 21(12). 1031–1034. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact